Unraveling the risks: A systematic review of factors leading to esophagojejunal dehiscence after gastric cancer surgery.
메타분석
1/5 보강
[BACKGROUND] Despite major advances in gastric cancer surgery, esophagojejunal anastomotic leakage (EJAL) remains a life-threatening complication after total gastrectomy.
- 연구 설계 systematic review
APA
Sentí I Farrarons S, Herrero Vicente C, et al. (2026). Unraveling the risks: A systematic review of factors leading to esophagojejunal dehiscence after gastric cancer surgery.. Surgery open science, 31, 24-32. https://doi.org/10.1016/j.sopen.2026.03.004
MLA
Sentí I Farrarons S, et al.. "Unraveling the risks: A systematic review of factors leading to esophagojejunal dehiscence after gastric cancer surgery.." Surgery open science, vol. 31, 2026, pp. 24-32.
PMID
41884788 ↗
Abstract 한글 요약
[BACKGROUND] Despite major advances in gastric cancer surgery, esophagojejunal anastomotic leakage (EJAL) remains a life-threatening complication after total gastrectomy. Its management is controversial and challenging, encompassing conservative treatment, endoscopic therapy, and surgical reintervention. Given its clinical impact, identifying predictive risk factors is essential to reduce incidence, enable early diagnosis, and improve outcomes. This systematic review aims to evaluate risk factors associated with esophagojejunal anastomotic failure and to propose preventive strategies.
[METHODS] Two independent reviewers conducted a systematic electronic search of PubMed, Cochrane Central Register of Controlled Trials, Embase, and Google Scholar up to June 2024. Search terms included OR AND OR , combined with , , , and . The protocol was registered in PROSPERO (CRD42021261841).
[RESULTS] A total of 221 studies were identified. After removal of duplicates and irrelevant studies, 18 studies met inclusion criteria. No additional studies were identified through cross-referencing. Study selection is summarized in a PRISMA flow diagram.
[CONCLUSIONS] Preoperative, intraoperative, and postoperative risk factors for esophagojejunal anastomotic leakage were identified and analyzed. Comprehensive knowledge of these factors is crucial to guide preventive strategies and ultimately reduce the incidence of this severe complication.
[METHODS] Two independent reviewers conducted a systematic electronic search of PubMed, Cochrane Central Register of Controlled Trials, Embase, and Google Scholar up to June 2024. Search terms included OR AND OR , combined with , , , and . The protocol was registered in PROSPERO (CRD42021261841).
[RESULTS] A total of 221 studies were identified. After removal of duplicates and irrelevant studies, 18 studies met inclusion criteria. No additional studies were identified through cross-referencing. Study selection is summarized in a PRISMA flow diagram.
[CONCLUSIONS] Preoperative, intraoperative, and postoperative risk factors for esophagojejunal anastomotic leakage were identified and analyzed. Comprehensive knowledge of these factors is crucial to guide preventive strategies and ultimately reduce the incidence of this severe complication.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates.
- Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in -amplified gastric cancer.
- Association of preoperative frailty and prognostic nutritional index with postoperative delirium in elderly gastric cancer patients: A single-center observational study.
- Complete response to Nivolumab-based chemotherapy in a case of advanced gastric cancer with multiple immune-related adverse events.
- Apatinib and silver nanoparticles synergize against gastric cancer through the PI3K/Akt signaling pathway-mediated ferroptosis.
- Correction: Survival disparities and predictors in gastric cancer: a population-based study from Kazakhstan (2012-2023).